weather icon Clear

Henderson woman accused of selling ‘do-it-yourself’ Botox

Updated March 9, 2017 - 5:43 pm

Federal prosecutors on Thursday announced a 25-count indictment against a Henderson woman accused of selling “do-it-yourself” Botox.

Kelly Schaible, 55, owned several beauty product websites, through which she is accused of selling “cheaper, non-FDA approved foreign versions of the prescription drug, Botox, and the prescription device, Juvederm.”

Both Botox and Juvederm, which is injectable, are expensive cosmetics used to treat facial wrinkles. They both are closely regulated by the Food and Drug Administration.

According to the indictment, which a federal grand jury returned last month, Schaible purchased the wrinkle reduction products from Chinese distributors and illegally imported them into the United States. Authorities allege the scheme started in 2009 and continued through 2014.

Schaible also is accused of selling the products to customers in foreign countries. She would market the products as do-it-yourself cosmetics for which a prescription was not necessary, according to the indictment.

She is accused of selling nearly 10,000 units of misbranded prescription drugs. According to the indictment, she reaped $1.7 million from the phony Botox sales and roughly $630,000 in sales revenue from misbranded Juvederm.

When federal agents with the Food and Drug Administration conducted searches as part of the investigation, Schaible attempted to destroy a plastic bag containing vials of botulinum, prosecutors said. Botulinum is the active ingredient in Botox.

Schaible was charged with nine counts of wire fraud, six counts of mail fraud, four counts of introduction of misbranded drugs into interstate commerce, five counts of introduction of misbranded medical devices into interstate commerce, and one count of destruction of evidence. Her trial is scheduled for May 8.

Contact Jenny Wilson at jenwilson@reviewjournal.com or 702-384-8710. Follow @jennydwilson on Twitter.

Don't miss the big stories. Like us on Facebook.